To determine if inhibition of NF-κB activity would in turn suppress CpG-685-mediated upregulation of IL21R, CLL patient cells were incubated concurrently with CpG-685 and the IKK-β inhibitor Bay 11. This evidence concerns the gene IKBKB and B-cell chronic lymphocytic leukemia.